David J. Perry, MD
Provider accepts MedStar Select insurance

Specialities: Radiation Oncology

Languages: English

(410) 682-2783

About me

David J. Perry, MD, a board-certified radiation oncologist, is chief of Radiation Oncology at MedStar Franklin Square Medical Center and medical director of the hospital's CyberKnife program. Dr. Perry is one of a just a handful of physicians in the region certified in the use of CyberKnife, a state-of-the-art technology that makes is possible to treat inoperable or surgically difficult tumors safely and painlessly without an incision. He also has extensive clinical training in the use of brachytherapy and Intensity-modulated radiation therapy (IMRT) to treat cancer and noncancerous tumors. He specializes in the treatment of gynecologic, prostate, lung, head and neck, genitourinary and gastrointestinal cancers as well as sarcomas.

Dr. Perry completed his residency at the Karmanos Cancer Institute in Detroit, Michigan and completed a fellowship at the Memorial Sloan-Kettering Cancer Center in New York.

Dr. Perry is a member of several professional organizations including the American Society of Therapeutic Radiation Oncology, the American Brachytherapy Society, the International Association for the Study of Lung Cancer and The Radiosurgery Society.

Dr. Perry was named a 2020 "Top Doc" by Baltimore magazine for radiation oncology.

Practice locations

Distance from Change LocationEnter your Location

12 Medstar Boulevard
Bel Air, MD, 21015

410-877-8170

Fax 410-877-8171

Get Directions

miles away

Fax 410-877-8171

9105 Franklin Square Drive
Franklin Square Rad/Onc Center Ste 100
Baltimore, MD, 21237

410-682-6800

Fax 410-682-2783

Get Directions

miles away

Fax 410-682-2783

Videos

Education

Fellowship Program: Memorial Sloan Kettering Cancer Center (2007)

Residency Program: Karmanos Cancer Institute (2006)

Internship Program: Beaumont Hospital Dearborn (2002)

Medical School: University of Michigan-Ann Arbor (2001)

Awards

    • Baltimore Magazine, Top Doc, 2019 & 2020